CD8A and neoplasm: (91) found that the combination of cryoablation with CTLA-4 inhibitors was more effective in inhibiting secondary tumor growth compared to monotherapy, and significantly increased the number of CD4+T and CD8+T cells in the tumor, as well as the ratio of effector T cells to Treg.